IS BETA(2)-MICROGLOBULIN A MEDIATOR OF BONE-DISEASE

[11] Knudsen P.J., Leon J., Ng A.K., Shaldon S., Floege J., Koch K., Hemodialysis related induction of β₂-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes, Nephron, 53, pp. 188-193, (1989)

[12] Miyata T., Oda O., Inagi R., Iida Y., Araki N., Yamada N., Horiuchi S., Taniguchi N., Maeda K., Kinoshita T., β₂-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis, J Clin Invest, 92, pp. 1243-1252, (1993)

[13] Miyata T., Inagi R., Iida Y., Sato M., Yamada N., Oda O., Maeda K., Seo H., Involvement of β₂-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1, J Clin Invest, 93, pp. 521-528, (1994)

[14] Morita T., Suzuki M., Kamimura A., Hirasawa Y., Amyloidosis of a possible new type in patients receiving long-term hemodialysis, Arch Pathol Lab Med, 109, pp. 1029-1032, (1985)

[15] Nishi S., Ogino S., Maruyama Y., Homma N., Gejyo F., Morita T., Arakawa M., Electron-microscopic and immunohistochemical study of β₂-microglobulin-related amyloidosis, Nephron, 56, pp. 357-363, (1990)

[16] Ogawa H., Saito A., Oda O., Nakajima M., Chung T.G., Detection of novel β₂-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition, Clin Nephrol, 30, pp. 158-163, (1988)

[17] Shirahama T., Skinner M., Cohen A.S., Gejyo F., Arakawa M., Suzuki M., Hirasawa Y., Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as β₂-microglobulin, Lab Invest, 53, pp. 705-709, (1985)

[18] Vincent C., Revillard J.P., Galland M., Traeger J., Serum β₂-microglobulin in hemodialyzed patients, Nephron, 21, pp. 260-268, (1978)

[19] Zingraff J.J., Noel L.H., Bardin T., Atienza C., Zins B., Kuntz D D.T.B., β₂-microglobulin amyloidosis as a complication of chronic renal failure?, N Engl J Med, 323, pp. 1070-1071, (1990)

[20] Campistol J.M., Cases A., Torras A., Sole M., Munoz-Gomez J., Montoliu J., Lopez-Pedret J., Revert L.I., Visceral involvement of dialysis-amyloidosis, Am J Nephrol, 7, pp. 390-393, (1987)

[11] Knudsen P.J., Leon J., Ng A.K., Shaldon S., Floege J., Koch K., Hemodialysis related induction of β₂-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes, Nephron, 53, pp. 188-193, (1989)

[12] Miyata T., Oda O., Inagi R., Iida Y., Araki N., Yamada N., Horiuchi S., Taniguchi N., Maeda K., Kinoshita T., β₂-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis, J Clin Invest, 92, pp. 1243-1252, (1993)

[13] Miyata T., Inagi R., Iida Y., Sato M., Yamada N., Oda O., Maeda K., Seo H., Involvement of β₂-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1, J Clin Invest, 93, pp. 521-528, (1994)

[14] Morita T., Suzuki M., Kamimura A., Hirasawa Y., Amyloidosis of a possible new type in patients receiving long-term hemodialysis, Arch Pathol Lab Med, 109, pp. 1029-1032, (1985)

[15] Nishi S., Ogino S., Maruyama Y., Homma N., Gejyo F., Morita T., Arakawa M., Electron-microscopic and immunohistochemical study of β₂-microglobulin-related amyloidosis, Nephron, 56, pp. 357-363, (1990)

[16] Ogawa H., Saito A., Oda O., Nakajima M., Chung T.G., Detection of novel β₂-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition, Clin Nephrol, 30, pp. 158-163, (1988)

[17] Shirahama T., Skinner M., Cohen A.S., Gejyo F., Arakawa M., Suzuki M., Hirasawa Y., Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as β₂-microglobulin, Lab Invest, 53, pp. 705-709, (1985)

[18] Vincent C., Revillard J.P., Galland M., Traeger J., Serum β₂-microglobulin in hemodialyzed patients, Nephron, 21, pp. 260-268, (1978)

[19] Zingraff J.J., Noel L.H., Bardin T., Atienza C., Zins B., Kuntz D D.T.B., β₂-microglobulin amyloidosis as a complication of chronic renal failure?, N Engl J Med, 323, pp. 1070-1071, (1990)

[20] Campistol J.M., Cases A., Torras A., Sole M., Munoz-Gomez J., Montoliu J., Lopez-Pedret J., Revert L.I., Visceral involvement of dialysis-amyloidosis, Am J Nephrol, 7, pp. 390-393, (1987)